Adenosine has been implicated as a regulatory metabolite in such diverse processes as coronary blood-flow regulation (Berne, 1964) , fat-cell lipolysis (Schwabe et al., 1973) , neurotransmitter release (Phillis et al., 1979) and platelet aggregation (Haslam et al., 1978) . Despite considerable progress in understanding the mechanism of action of adenosine (Londos et al., 1978 ) the mechanism and control of adenosine production remain the subject of conjecture and hypothesis (Berne, 1980; Arch & Newsholme, 1978) . The enzyme generally assumed to be responsible, the plasma-membrane 5'-nucleotidase, has been shown to be an ecto-enzyme (i.e. to have its catalytic site on the external membrane face; De Pierre & Karnovsky, 1974; Newby et al., 1975) and furthermore to be unessential for the hydrolysis of intracellularly generated IMP (Newby, 1980) . However, its role in adenosine production from AMP has remained unclear. At least in the synaptic cleft or during platelet aggregation, adenosine may arise by the action of the ecto-enzyme on extracellular AMP (Dowdall, 1978; Pearson et al., 1980) . However, in the perfused heart, evidence has been presented for intracellular adenosine synthesis (Frick & Lowenstein, 1976) . In view of the cellular complexity and multiple compartments in the perfused organ, it was essential to examine this question in an intact isolated cell. A further complication in studying adenosine production has been the ubiquitous presence of adenosine-metabolizing enzymes. This was circumvented in one study (Matsumoto et al., 1979) by using a mutant lymphoblastoid cell line which lacked the enzyme adenosine kinase (EC 2.7.1.20) . Adenosine deaminase (EC 3.5.4.4) was inhibited, as in the present work, with 2'-deoxyVol. 200 coformycin. The characterization of adenosine kinase inhibitors which are effective on the enzyme in intact cells (Newby, 1981) opens up the possibility of extending such studies to a wide variety of normal cells. In the first application of this strategy, we have established unequivocally that adenosine may be synthesized within an intact cell by a pathway independent of the ecto-5'-nucleotidase. We propose the existence of distinct metabolic pathways for the generation of adenosine from intracellular and extracellular nucleotides. Experimental 2'-Deoxycoformycin {R-3-(2-deoxy-fl-D-erythropentofuranosyl) - 3, 6, 7, Rat polymorphonuclear leucocytes were obtained 98% pure and incubated in Krebs-Ringer bicarbonate buffer as described previously (Newby, 1980) . Termination of incubations with trichloroacetic acid and processing of samples for high-pressure liquid chromatography were also described there. Metabolite standards added immediately after trichloroacetic acid precipitation were completely recovered and did not suffer conversion into detectable amounts of any other metabolite measured.
Determination of metabolites was improved by a slight modification of the previously published chromatography method (Newby, 1980 (Newby, 1980) , except for adenosine. This was identified by collecting the column effluent (from approx. 107 cells) containing the peak with retention time 9.2min. The effluent was free from 2'-deoxycoformycin and hence could be treated with adenosine deaminase (1 unit for 10min at 37°C). On rechromatography, no peak corresponding to adenosine was found, but a quantitatively equivalent peak with retention time 3.6 min corresponding to inosine was found.
Results and discussion
Catabolism of adenine nucleotides was induced by incubation in the absence of glucose with 5 mM-2-deoxyglucose, an analogue which may be phosphorylated but not further metabolized. Rapid catabolism of ATP (74 + 4%, paired results from 11 experiments) resulted in 2 min at 370C (Table 1) . This was followed by a slower decline to 14.9 + 0.7% (paired results from 26 experiments) by 10min. Over this period lactate dehydrogenase (EC 1.1.1.27) release from the cells, an assay of cell breakage, rose from 0.93 + 0.07% (30) to 1.28 + 0.13% (22) of the homogenate value. ADP concentration increased by approx. 50% at 2min, but then declined to control values at 10min (Table   1) . AMP concentration, on the other hand, rose about 5-fold and remained elevated to 10min. IMP concentration showed an initial dramatic increase, followed by a slower fall. Inosine and hypoxanthine accumulated as the end-products of nucleotide catabolism ( Table 1 ), provided that an inhibitor of xanthine oxidase (EC 1.2.3.2) was present. Allopurinol (4-hydroxypyrazolo[3,4-d]pyrimidine; 10UM) was maximally effective and had no effect on any other metabolite concentrations measured (results not shown). These observations indicated that a low activity of xanthine oxidase (<0.5 nmol/ min per 10' cells; Newby, 1980 ) is present in polymorphonuclear leucocytes. The accumulation of hypoxanthine as the end-product of cyanide-induced adenine nucleotide catabolism (Newby, 1980) is explained by the known inhibitory effect of cyanide on xanthine oxidase (Bray, 1975 (Wotring & Townsend, 1979; Newby, 1981) in combination with 2'-deoxycoformycin, a tight-binding inhibitor of adenosine deaminase (Agarwal et al., 1977) . The inhibitors were used at concentrations previously shown maximally to inhibit their target enzymes in situ in intact polymorphonuclear leucocytes (Newby, 1980 (Newby, , 1981 .
On addition of 2-deoxyglucose, adenosine accumulated rapidly to 0.33 + 0.04 (7)nmol/107 cells at 2 min and then more slowly to 0.52 + 0.06 (23)nmol/10' cells at 10min (Fig. 1) . Inhibition of adenosine kinase alone did not lead to accumulation of adenosine (results not shown), whereas inhibition of the deaminase only led to a sub-maximal and transient accumulation (Fig. 1) The increase in adenosine concentration at 10min was equivalent to 5.9 +0.6%(8) of the fall in ATP concentration and was too small to be reflected in a statistically significant change of any other metabolite (results not shown). These data confirm that degradation of AMP to adenosine is a minor catabolic route in these cells, most of the hypoxanthine arising from IMP and inosine (Newby, 1980) . To determine whether adenosine was formed within the polymorphonuclear leucocytes, cells were rapidly separated from their surrounding medium. The amount of adenosine present in the supernatant was compared with that in the whole cell suspension (Fig. 2) . The amount of adenosine in the cell pellet is not recorded, since the considerable time and harsh conditions needed for its resuspension resulted in additional adenosine synthesis. The data show that only 11% of the adenosine synthesized in response to 2-deoxyglucose was present in the medium at 2 min. This value increased to 19% at 5min. At this cell dilution 95% of the total water was extracellular. It was therefore concluded that adenosine was synthesized inside the cells and a proportion was subsequently transported into the medium.
A combination of inhibitory antibodies raised to rat liver ecto-5'-nucleotidase (Stanley et al., 1980) and lOmM-J-glycerophosphate inhibited the ectophosphatases of rat polymorphonuclear leucocytes by 98% (Newby, 1980) . When cells so inhibited were treated with deoxyglucose, the same changes in metabolite concentrations occurred as in control cells (results not shown). In particular, the rate of hypoxanthine accumulation recorded in three timecourse experiments was 0.65, 0.75 and 1.35 nmol/ min per 107 cells. The residual ecto-phosphatase activity in the presence of inhibitors was 0.14, 0.17 and 0.15 nmol/min per 10' cells respectively. This data amplified our previous conclusion that catabolism of IMP to hypoxanthine did not require ecto-phosphatases (Newby, 1980) .
To test the effect of antibodies and fl-glycerophosphate on adenosine synthesis directly, cells were incubated in the simultaneous presence of these agents and the inhibitors of adenosine metabolism. Since at 37°C the rate of adenosine production might already be slowed at the first 2 min time-point (Figs. 1 and 2), these experiments were conducted at 25°C. Fig. 3 shows that the maximal rate of adenosine synthesis, measured between 2 and 5 min was unaffected by 98% inhibition of ecto-phosphatase activity. This suggested that intracellular adenosine synthesis had a distinct enzymic mechanism. Further experiments will be necessary to establish the nature of this mechanism. Several mammalian cells (Stanley et al., 1980) , including polymorphonuclear leucocytes (Newby, 1980) , contain an internal pool of the ecto-enzyme, although this is thought to be confined to the intravesicular surface of subcellular vesicles (Stanley et al., 1980) cytoplasmic 5'-nucleotidase has been detected in liver (Fritzon, 1969) and also in polymorphonuclear leucocytes (Newby, 1980) . Its possible role in adenosine production should be tested. A third possibility is that adenosine arises from S-adenosylhomocysteine (Schrader et al., 1981) . We view this as an unlikely explanation for our results, since the concentration of this metabolite remained unaltered and below 0.06nmol/107 cells under all the conditions of the present study. There is also no established mechanism for increased synthesis of S-adenosylhomocysteine during energy depletion.
Catabolism of extracellular AMP by ecto-5'-nucleotidase can explain the generation of adenosine in the synaptic cleft and during platelet aggregation (Dowdall, 1978; Pearson et al., 1980 ). The present work demonstrates an alternative route for intracellular adenosine production. The similarities in this process in polymorphonuclear leucocytes and in the perfused heart (Frick & Lowenstein, 1976) encourage the belief that this mechanism is physiologically important. In both cell types, the rate of adenosine production appears to be low in the normal state (Fig. 1 ), but on energy depletion a prompt and pronounced acceleration takes place. The strategy outlined above, by greatly exaggerating the accumulation of adenosine in a non-perfused system, permits its easy determination by the currently available methods. Also, by allowing the measurement of adenosine production in the absence of degradation, it should greatly facilitate the study of the mechanism and control of this important regulatory process.
